Epilepsia
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.6 | Q1 | 89.5% | 2.203 | Q1 | 96.1% |
| 2024 | 6.6 | Q1 | 91.6% | 2.371 | Q1 | 96.6% |
| 2023 | 6.6 | Q1 | 93.1% | 2.227 | Q1 | 96.3% |
| 2022 | 5.6 | Q1 | 89.8% | 1.966 | Q1 | 95.6% |
| 2021 | 6.7 | Q1 | 91.7% | 1.893 | Q1 | 95.5% |
| 2020 | — | — | 2.687 | Q1 | 97.4% | |
| 2019 | — | — | 2.484 | Q1 | 97.0% | |
| 2018 | — | — | 2.850 | Q1 | 97.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0013-9580
ISSN
1528-1167
country
GBcoverage
1909-1915, 1937-1950, 1952-1955, 1959, 1961-2026